Dis-Chem Pharmacies Limited

As of February 28, 2025, Dis-Chem Pharmacies Limited carries a market capitalization of 2.80T, placing it among publicly traded companies globally. Its enterprise value stands at 3.36T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Dis-Chem Pharmacies Limited's next confirmed earnings release is scheduled for November 4, 2026.

As of February 28, 2025, Dis-Chem Pharmacies Limited has 856.97M shares outstanding.

These figures are as of February 28, 2025.

As of February 28, 2025, Dis-Chem Pharmacies Limited maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended February 28, 2025.

As of the close on October 22, 2026, Dis-Chem Pharmacies Limited's stock has declined approximately 16.93% over the past 52 weeks. The 50-day moving average sits at 2,753.02, while the 200-day moving average is 3,295.76.

As of February 28, 2025, Dis-Chem Pharmacies Limited holds 58.54B in cash and equivalents against 623.53B in total debt, resulting in a net debt position of 298.61B. Total book value stands at 521.82B, with working capital of 176.71B providing operational flexibility.